Last updated 2026-07-20
- Raised $6M Undisclosed Round, Jan 2016
Total raised
$6.0M
Last: Undisclosed Round 2016-01
Stage
Seed
Founded
2015
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
BioNanoSim (BNS) is an Israeli startup focused on developing drug delivery technology using proprietary nano-encapsulation to improve the delivery, stability, and bioactivity of drugs. The company, a spin-off from the Hebrew University, reformulates existing drugs and creates new therapeutic products across various verticals including ophthalmology, obesity, oncology, and cannabis. In 2023, BioNanoSim partnered with Greek pharma firm RAFARM to create BNS Ophthalmics (BNSO), a new company dedicated to marketing novel treatments for eye diseases.
Funding history · 1 round · $6.0M total
2016-01
Undisclosed Round
$6.0M
Headcount over time
From 12 (2019-11) to 6 (2025-10) · -6 (-50%) · 4 points · source: Finder history + radar grounding
Q&A
- What is BioNanoSim's primary focus?
- BioNanoSim (BNS) specializes in developing a proprietary technology platform for the nano-encapsulation of drugs to enhance delivery profiles and therapeutic performance.
- When was BioNanoSim founded?
- BioNanoSim was founded in July 2015.
- Where is BioNanoSim headquartered?
- BioNanoSim is headquartered in Jerusalem, Jerusalem District, Israel.
- How much funding has BioNanoSim raised to date?
- BioNanoSim has raised a total of $6,000,000 USD.
- When was BioNanoSim's last funding round?
- BioNanoSim's last funding round occurred in January 2016, raising $6,000,000 USD.
- What is BioNanoSim's current employee count?
- BioNanoSim has 1-10 employees.
- Who is the founder of BioNanoSim?
- Professor Simon Benita is the Founder & Chairman of BioNanoSim.
- What therapeutic areas does BioNanoSim's technology address?
- BioNanoSim's nano-encapsulation technology has potential applications across oncology, ophthalmology, and metabolic diseases. Additionally, the company is developing topical and ocular cannabis-based products.
Team · 1
Prof. Simon Benita
Founder · Founder, CEO & Chairman
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical Cannabis
Technologies
Materials & Substances
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
pharma-companiescancerpharmaceuticalsnanotechnologydrug-deliveryhealthcare-providerscannabistreatmentsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | bionanosim.com/ |
|---|---|
| linkedin.com/company/77224750 |
Identifiers & details
| Founded | 2015 |
|---|---|
| Employees (exact) | 6 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | bionanosim.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515268241 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-06-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 3 — shares_capital (2), other (1) |
| Registered address | ויסבורג חיים 6 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2025-09-18 | העברת מניות |
| 2025-09-11 | הקצאת מניות |
| 2026-06-04 | עדכון כתובת ו/או מען דיגיטלי |